N-Acetyl Cysteine (NAC): Clinical Evidence & Substantiation Summary

Clinical Trials
72
Strongest Evidence
Antioxidant & Respiratory
Typical Dosage
600–1,800 mg/day
Common Forms
NAC capsules (600 mg)

What Is N-Acetyl Cysteine (NAC)?

NAC is a precursor to glutathione, the body's master antioxidant. It has broad clinical applications including respiratory health, liver protection, mental health, and immune function. Its use in supplement form was briefly challenged by FDA in 2020 but has since been resolved.

Mechanism of action: NAC donates a cysteine molecule for glutathione synthesis, the body's primary endogenous antioxidant. It breaks disulfide bonds in mucus (mucolytic effect), chelates heavy metals, modulates glutamate signalling via the cystine-glutamate antiporter, and inhibits NF-κB activation.

Clinical Evidence Summary

Below are 3 key clinical studies on N-Acetyl Cysteine (NAC). Nutra Comp analyses 72+ studies in its full clinical evidence report.

Meta-analysis2016PMID: 26515950

NAC for prevention of COPD exacerbations: a meta-analysis

Population: 13 RCTs, 4,155 patients

Key finding: NAC (≥1,200 mg/day) significantly reduced COPD exacerbation frequency by 25% (RR 0.75, 95% CI 0.62–0.92).

Systematic review2019PMID: 30193758

NAC and mental health: a systematic review

Population: 16 RCTs

Key finding: NAC showed significant benefits as adjunctive treatment for depression (SMD: -0.37, p=0.001), OCD, and addiction disorders.

Meta-analysis2019PMID: 31364729

NAC supplementation and oxidative stress markers

Population: 9 RCTs

Key finding: NAC significantly increased total antioxidant capacity (p=0.002) and glutathione levels (p<0.001) while reducing MDA (a lipid peroxidation marker).

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

9
Supports healthy glutathione levels for antioxidant defence
Category: Antioxidant · Confidence: 9/10
8
Supports respiratory health and normal mucus production
Category: Respiratory · Confidence: 8/10
7
Supports liver health and detoxification processes
Category: Liver Health · Confidence: 7/10

Get the full substantiation report for N-Acetyl Cysteine (NAC)

Includes all 72+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Vitamin C
168 studies · Immune Function
Selenium
64 studies · Thyroid Function

Key Terms

Randomised Controlled Trial (RCT)Meta-AnalysisAdverse Event Reporting

Frequently Asked Questions

Is NAC FDA approved?

NAC is approved as an OTC drug (Mucomyst) and was briefly challenged as a supplement. FDA issued enforcement discretion guidance in 2022, allowing continued sale as a dietary supplement.

What are the most studied benefits?

The strongest evidence supports NAC for glutathione support, respiratory health (reducing COPD exacerbations), and as adjunctive support in mental health conditions.

What dosage is used in clinical studies?

Most studies use 600–1,800 mg/day, divided into 2–3 doses. The respiratory meta-analysis found 1,200 mg/day as the minimum effective dose.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist